Rossari Biotech Ltd

Read More

• Rossari Biotech is one of India’s leading chemical and textile manufacturers. The company’s products are used in the paper, construction, pharmaceutical, animal health, and nutrition industries. It has operations in India, Vietnam, Bangladesh, and Mauritius. The company, founded in 2003, operates two research and development facilities in India. It is headquartered in Mumbai, India. 

  On 22 January 2023, the market capitalisation of the company was Rs 3,926.82 crore. It reported a total revenue of Rs 240.9 crore at the end of the second quarter of the financial year 2022-2023. The company is listed on the Bombay Stock Exchange with the code 543213 and on the National Stock Exchange under the code ROSSARI.   

  Rossari Biotech has a diversified shareholding pattern, with promoters holding approximately 68.44% of the company. The public has a stake of 8.87% in the company. FIIs hold a stake of 8.61% in the company, while DIIs hold 14.08%. The shareholding pattern of the company has remained largely stable over the past year.

  Edward Menezes is the current chairman of the company. Other directors of the company include Sunil Chari, Aseem Dhru, Goutam Bhattacharya, Meher Castelino, Robin Banerjee, and Sharabh Pachory. The chief financial officer of Rossari Biotech is Ketan Sablok. The company’s auditors are Deloitte Haskins & Sells LLP.  

  On 22 January 2023, Rossari Biotech’s share price was Rs 710.85 on the BSE and Rs 710.35 on the NSE. The company’s 52-week-high was Rs 1,283.15, while the 52-week-low was Rs 648.00. Its three-month return to investors was -24.6%, while its one-year return was -43.3%.

  The company’s trailing twelve-month (TTM) revenue was Rs 1,482.97 crore as of 31 December 2022. At the same time, the company had a net profit of Rs 97.70 crore. The company’s P/E TTM was 39.4. The ROE of the company was 16.1, while the ROCE of the company was 22.7.

  Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.